Cite
APA Citation
Hirbe, A., Luo, J., Seetharam, M., Toeniskoetter, J., Kershner, T., Agulnik, M., Varun, M., Milhem, M., Parkes, A., Robinson, S., Okuno, S., Attia, S., & Van Tine, B. A. (n.d.). 1677PDA phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft tissue sarcomas who are not candidates for chemotherapy. Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100097079760.0x000029